This page has been translated automatically into English by Google Translate. Always consult with your healthcare team for any medical concerns. All PDFs and printed documents are only available in English.
News & Updates
News & Updates
England’s Managed Access Agreement for Nusinersen extended to July 2025
Information
Treatments & Research
Scholar Rock presents latest TOPAZ Trial data at the international scientific congress on SMA
Information
Treatments & Research
Food and Drug Administration (FDA) in U.S. approves Evrysdi® (Risdiplam) to include babies under 2 months old with SMA
